Cleared Traditional

K954145 - WAKO AUTOKIT CH50 (FDA 510(k) Clearance)

Dec 1995
Decision
104d
Days
Class 2
Risk

K954145 is an FDA 510(k) clearance for the WAKO AUTOKIT CH50. This device is classified as a Complement C9, Antigen, Antiserum, Control (Class II - Special Controls, product code DAE).

Submitted by Wako Chemicals USA, Inc. (Richmond, US). The FDA issued a Cleared decision on December 18, 1995, 104 days after receiving the submission on September 5, 1995.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5240.

Submission Details

510(k) Number K954145 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 05, 1995
Decision Date December 18, 1995
Days to Decision 104 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code DAE — Complement C9, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5240

Similar Devices — DAE Complement C9, Antigen, Antiserum, Control

Optilite CH50 Reagent, Optilite CH50 Controls and Optilite CH50 Calibrator
K150412 · The Binding Site Group , Ltd. · Aug 2015
HUMAN CH50 REAGENT PACK FOR USE ON THE SPAPLUS, HUMAN CH50 CALIBRATOR SET FOR USE ON THE SPAPLUS, HUMAN CH50 CONTROLS FO
K113349 · The Binding Site Group , Ltd. · Jul 2012
TOTAL HAEMOLYTIC COMPLEMENT RID KIT
K992488 · The Binding Site, Ltd. · Sep 1999
QUIDEL CH50 EQ EIA
K974111 · Quidel Corp. · Jul 1998
COMPLEMENT ACTIVATION EIA TEST SYSTEM (CAE)
K951639 · Incstar Corp. · Oct 1995